Lorem Ipsum - jan.ucc.nau.edu
... decarboxylase inhibitor that is combined with levadopa which enables levadopa to get to and cross over the blood-brain barrier This medication combination is called Sinemet ...
... decarboxylase inhibitor that is combined with levadopa which enables levadopa to get to and cross over the blood-brain barrier This medication combination is called Sinemet ...
Perphenazine Fact Sheet - The Main Line Center for the Family
... such as chlorpromazine and thioridazine, which are low-potency agents, and fluphenazine and Haldol (haloperidol), which are high-potency antipsychotics. Perphenazine is moderately sedating and less likely to lower blood pressure than the lower-potency agents. Perphenazine produces fewer EPS than the ...
... such as chlorpromazine and thioridazine, which are low-potency agents, and fluphenazine and Haldol (haloperidol), which are high-potency antipsychotics. Perphenazine is moderately sedating and less likely to lower blood pressure than the lower-potency agents. Perphenazine produces fewer EPS than the ...
Possible Test Questions
... - SERT – Serotonin Transporter – Serotoin Reuptake Inhibitors (SRI’s or SSRI’s) – i.e. some drugs, particularly the SSRIs, blockade (antagonize) the SERT leading to ↓ reuptake of serotonin back into the presynaptic neurons and ↑ serotonin present in the synapse down regulation of serotonin recep ...
... - SERT – Serotonin Transporter – Serotoin Reuptake Inhibitors (SRI’s or SSRI’s) – i.e. some drugs, particularly the SSRIs, blockade (antagonize) the SERT leading to ↓ reuptake of serotonin back into the presynaptic neurons and ↑ serotonin present in the synapse down regulation of serotonin recep ...
Schizophrenia II - Psychiatry Training
... – Prolactin elevation and extrapyramidal side effects (EPS) were characteristic side effect (e.g. haloperidol) – EPS: parkinsonism, akathisia, dystonia; were thought to be inextricably linked with antipsychotic efficacy ...
... – Prolactin elevation and extrapyramidal side effects (EPS) were characteristic side effect (e.g. haloperidol) – EPS: parkinsonism, akathisia, dystonia; were thought to be inextricably linked with antipsychotic efficacy ...
ANTI-PSYCHOTIC DRUGS
... TCA(-) NorE and serotonin reuptake pump “OFF-SWITCHES” of the amine transmission MAO inhibitors (-) major degradation pathway resulting A. ...
... TCA(-) NorE and serotonin reuptake pump “OFF-SWITCHES” of the amine transmission MAO inhibitors (-) major degradation pathway resulting A. ...
The drugs discussed in this chapter are used to alter an individual`s
... Increases the intraneuronal stores of norepinephrine and dopamine slightly; o and decreases intraneuronal content of second messengers. Treatment of manic episodes of manic-depressive illness; maintenance therapy to prevent or diminish the frequency & intensity of future manic episodes; not recommen ...
... Increases the intraneuronal stores of norepinephrine and dopamine slightly; o and decreases intraneuronal content of second messengers. Treatment of manic episodes of manic-depressive illness; maintenance therapy to prevent or diminish the frequency & intensity of future manic episodes; not recommen ...
CNSDrugs - shabeelpn
... thoughts – Probable cause: increased dopamine release – Tx. Aimed at decreasing dopamine activity Two Chemical Classes: ...
... thoughts – Probable cause: increased dopamine release – Tx. Aimed at decreasing dopamine activity Two Chemical Classes: ...
Basic Pharmacology of the Alpha
... Labetalol has been used in Hypertensive Emergencies In theory, ...
... Labetalol has been used in Hypertensive Emergencies In theory, ...
July 2013
... others. All antipsychotics are associated with an increased stroke and mortality risk when used to treat behavioural problems in the elderly with dementia. There are many other side effects, including Parkinson-like effects, increased falls, drowsiness, and cognitive decline. Evidence shows that the ...
... others. All antipsychotics are associated with an increased stroke and mortality risk when used to treat behavioural problems in the elderly with dementia. There are many other side effects, including Parkinson-like effects, increased falls, drowsiness, and cognitive decline. Evidence shows that the ...
TERAPI BIOLOGIK (Kuliah Umum Psikiatri Mhs.tk
... Accumbens, Amygdala & Hippocampus, and Prefrontal Cortex . Memory . Motivation and emotional response . Reward and desire . Addiction . Can cause hallucinations and schizophrenia if not functioning properly ...
... Accumbens, Amygdala & Hippocampus, and Prefrontal Cortex . Memory . Motivation and emotional response . Reward and desire . Addiction . Can cause hallucinations and schizophrenia if not functioning properly ...
4._Bipolar_disorder_def
... thoughts (particularly in shizophrenia and bipolar disorder) – At conditions of acute patologic agressivity and agitation (chlorpromazine, levopromazine, haloperidol) ...
... thoughts (particularly in shizophrenia and bipolar disorder) – At conditions of acute patologic agressivity and agitation (chlorpromazine, levopromazine, haloperidol) ...
4._Bipolar_disorder_def
... thoughts (particularly in shizophrenia and bipolar disorder) – At conditions of acute patologic agressivity and agitation (chlorpromazine, levopromazine, haloperidol) ...
... thoughts (particularly in shizophrenia and bipolar disorder) – At conditions of acute patologic agressivity and agitation (chlorpromazine, levopromazine, haloperidol) ...
Antipsychotics Antimanics Antidepressants
... Typical antipsychotics Mechanism of action All typical antipsychotics have potent dopamine D2 receptor blocking action. Blockade of D2 receptors to the temporal and prefrontal areas constituting the ‘limbic system’ is responsible for the antipsychotic action. Drugs which increase DA activity ...
... Typical antipsychotics Mechanism of action All typical antipsychotics have potent dopamine D2 receptor blocking action. Blockade of D2 receptors to the temporal and prefrontal areas constituting the ‘limbic system’ is responsible for the antipsychotic action. Drugs which increase DA activity ...
Biopsychosocial Model For Psychosis
... – lower EPSE – increased prolactin - breast enlargement/ galactorrhoea and menstrual problems ...
... – lower EPSE – increased prolactin - breast enlargement/ galactorrhoea and menstrual problems ...
Psychotropic Drugs
... Chronic movement disorder characterized by involuntary movements of the face, extremities, and trunk Occurs in up to 20% of patents receiving long term antipsychotics Generally once symptoms occur they are permanent however benztropine may help control symptoms ...
... Chronic movement disorder characterized by involuntary movements of the face, extremities, and trunk Occurs in up to 20% of patents receiving long term antipsychotics Generally once symptoms occur they are permanent however benztropine may help control symptoms ...
Chapter 16 Cholinesterase Inhibitors
... Abrupt withdrawal of antipsychotics can precipitate a mild abstinence syndrome ...
... Abrupt withdrawal of antipsychotics can precipitate a mild abstinence syndrome ...
Psychotherapeutic Drugs:
... – First line of drugs used for anxiety disorders – Produce sedation and muscle relaxation ...
... – First line of drugs used for anxiety disorders – Produce sedation and muscle relaxation ...
Blockade of D2 receptor increases prolactin release and causes
... 2. Butyrophenones – Haloperidol (Haldol) 3. Thioxanthenes – Thiothixene (Navane) ...
... 2. Butyrophenones – Haloperidol (Haldol) 3. Thioxanthenes – Thiothixene (Navane) ...
Pharmacology II - 2-22
... a. High potency typicals have a reduced risk of EPS b. Low potency typicals are less efficacious than higher potency antipsychotics c. Atypical antipsychotics have increased affinity for D2 as compared to typical antipsychotics d. Increased anticholinergic activity reduces the risk of EPS ...
... a. High potency typicals have a reduced risk of EPS b. Low potency typicals are less efficacious than higher potency antipsychotics c. Atypical antipsychotics have increased affinity for D2 as compared to typical antipsychotics d. Increased anticholinergic activity reduces the risk of EPS ...
Anti-psychotic Meds (CC)
... Antipsychotic medications treat the s/s of psychotic illnesses such as schizophrenia, manic and delusional disorders. These drugs do not cure psychotic illnesses: they are effective in managing symptoms as long as the patient takes them consistently. There are many adverse side effects with th ...
... Antipsychotic medications treat the s/s of psychotic illnesses such as schizophrenia, manic and delusional disorders. These drugs do not cure psychotic illnesses: they are effective in managing symptoms as long as the patient takes them consistently. There are many adverse side effects with th ...
Typical antipsychotic drugs
... Loxapine (typical), clozapine, olanzapine (atypical) Loxapine properties are similar to phenothiazines Clozapine has fewer extrapyramidal side effect and greater activity against negative symptoms and its use is with 1.3% first year incidence of potentially fatal agranulocytosis. Other atypical drug ...
... Loxapine (typical), clozapine, olanzapine (atypical) Loxapine properties are similar to phenothiazines Clozapine has fewer extrapyramidal side effect and greater activity against negative symptoms and its use is with 1.3% first year incidence of potentially fatal agranulocytosis. Other atypical drug ...
Anglická výuka
... relapse rates are lower with continuous antipsychotic therapy ! relapses with APs signif. lower than with placebo (circa 20% vs 50%) poor adherence leads to relapse and high costs to individuals, families, carers and society stopping medication is the most powerful predictor of relapse ...
... relapse rates are lower with continuous antipsychotic therapy ! relapses with APs signif. lower than with placebo (circa 20% vs 50%) poor adherence leads to relapse and high costs to individuals, families, carers and society stopping medication is the most powerful predictor of relapse ...
Léčiva působící prostř. histaminu, serotoninu a dopaminu
... • Serotonine receptors: 5HT1A, 5-HT2, 5-HT3, 5-HT „xyz“ Clinical effects of activation/inhibition of serotonine receptors 5HT-1A agonist = anxiolytic and antidepressant eff. 5-HT2 antagonist eff. = antipsychotic eff., improvement of ...
... • Serotonine receptors: 5HT1A, 5-HT2, 5-HT3, 5-HT „xyz“ Clinical effects of activation/inhibition of serotonine receptors 5HT-1A agonist = anxiolytic and antidepressant eff. 5-HT2 antagonist eff. = antipsychotic eff., improvement of ...
No Slide Title
... first atypical neuroleptic was clozapine ◦ effective in proportion of patients that were unresponsive to previous medication ◦ reduced negative symptoms ◦ reduced tardive dyskinesias ◦ risky side effects – agranulocytosis (potentially lethal drop in white blood cells ~ 1% of people on drug) ...
... first atypical neuroleptic was clozapine ◦ effective in proportion of patients that were unresponsive to previous medication ◦ reduced negative symptoms ◦ reduced tardive dyskinesias ◦ risky side effects – agranulocytosis (potentially lethal drop in white blood cells ~ 1% of people on drug) ...
Chlorpromazine
Chlorpromazine (CPZ) — marketed as Thorazine among others — is a dopamine antagonist of the typical anti-psychotic class of medications possessing additional antiadrenergic, anti-serotonergic, anticholinergic and antihistaminergic properties used to treat schizophrenia. First synthesized on December 11, 1951, chlorpromazine was the first drug developed with specific antipsychotic action and would serve as the prototype for the phenothiazine class of drugs, which comprises several other agents. The introduction of chlorpromazine during the 1950s has been described as the single greatest advance in the history of psychiatric care, improving the prognosis of people in psychiatric hospitals.Chlorpromazine works on a variety of receptors in the central nervous system, producing potent anticholinergic, antidopaminergic, antihistaminic, and antiadrenergic effects. Both the clinical indications and side effect profile of CPZ are determined by the broadness of its action: its anticholinergic properties cause constipation, sedation, and hypotension but also help relieve nausea. It also has anxiolytic (anxiety-relieving) properties. Its antidopaminergic properties can cause extrapyramidal symptoms, such as akathisia (restlessness, where the patient walks almost constantly, despite having nowhere to go due to mandatory confinement) and dystonia. It is known to cause tardive dyskinesia, which can be irreversible. In acute settings, it is often administered as a syrup, which has a faster onset of action than tablets, and it can also be given by intramuscular injection. IV administration is very irritating and is not advised; its use is limited to severe hiccups, surgery, and tetanus.Chlorpromazine is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.